Surgical Anesthesia and Cognitive Decline in Older Adults: Susana Vacas, MD, PhD
October 7th 2021The assistant professor of anesthesiology at the David Geffen School of Medicine, University of California–Los Angeles, discussed a recently published article that outlined an association between anesthesia during surgery and cognitive issues. [WATCH TIME: 4 minutes]
Takeaways From Telehealth Use in Sleep Medicine: Lucas Donovan, MD, MS
October 6th 2021The assistant professor in the division of pulmonary, critical care, and sleep medicine at the University of Washington discussed patients’ response to the use of telehealth when treating sleep disorders. [WATCH TIME: 2 minutes]
Prioritizing Women and Genetics in Alzheimer Disease Trials: Jessica Caldwell, PhD
October 6th 2021The director of the Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic discussed the role genetics play in Alzheimer disease and the importance for all-women trials. [WATCH TIME: 2 minutes]
Inebilizumab’s Efficacy in African Americans With NMOSD: Evanthia Bernitsas, MD
October 5th 2021The neurologist at Wayne State University School of Medicine discussed recently published data describing inebilizumab’s role in producing rapid and sustained B-cell depletion in African Americans with NMOSD [WATCH TIME: 4 minutes]
Current and Future Implications of Telehealth for Sleep Disorders: Lucas Donovan, MD, MS
October 4th 2021Following a study of patient experiences with telehealth in sleep medicine, the assistant professor in the division of pulmonary, critical care, and sleep medicine at the University of Washington shed light on the positive and negative aspects of its integration. [WATCH TIME: 4 minutes]
Findings From a Study of Telehealth in Sleep Medicine: Lucas Donovan, MD, MS
October 3rd 2021The assistant professor in the division of pulmonary, critical care, and sleep medicine at the University of Washington discussed key findings from a recent study on patient experience with telehealth encounters. [WATCH TIME: 3 minutes]
Lifestyle Interventions to Manage MS
Recommendations surrounding the use of complementary and natural therapies to manage symptoms of multiple sclerosis (MS).
Best practices for establishing treatment plans for patients with relapse-remitting multiple sclerosis (RRMS) and making decisions to switch therapies based on inadequate treatment responses, relapse, or disease progression.
Differences in Care for Millennial Patients With MS: Mitzi Joi Williams, MD
September 30th 2021As the MS patient population includes more patients from the millennial generation, the founder and CEO of the Joi Life Wellness Group Multiple Sclerosis Center offered her insight on the way care differs for this generation compared with prior ones. [WATCH TIME: 4 minutes]
Understanding Different Dietary Approaches for Epilepsy: Robyn Blackford, RD, LDN
September 30th 2021The registered dietician at Ann & Robert H. Lurie Children’s Hospital of Chicago discussed the variety of diets available to patients with epilepsy and how they differ from one another. [WATCH TIME: 3 minutes]
Effective Comprehensive Care Team Communication in MS: Patricia Bobryk, MHS, PT, MSCS, ATP
September 30th 2021The physical therapist at UC Health and cochair of the International Organization of MS Rehabilitation Therapists discussed the importance of the care team for patients with MS and the role effective communication plays. [WATCH TIME: 4 minutes]
Ongoing Challenges for Neuromuscular and Movement Occupational Therapy: Jess Holguin, OTD, OT/L
September 29th 2021Commenting on recent advances and persistent challenges for these patients, the associate professor of clinical occupational therapy at USC Keck Hospital spoke on the need to increase equity and access to care. [WATCH TIME: 6 minutes]
State of Care for Neuromuscular Disease and Movement Disorders: Jess Holguin, OTD, OT/L
September 28th 2021The associate professor of clinical occupational therapy at USC Keck Hospital discussed the growing awareness for the care of these patients, as well as the integration of occupational therapists. [WATCH TIME: 2 minutes]
AMX0035’s Potential and Mechanism in ALS: Sabrina Paganoni, MD, PhD
September 28th 2021With AMX0035 expected to be submitted to the FDA for review in the coming months, the investigator at the Healey & AMG Center for ALS at Massachusetts General Hospital chimed in to share her thoughts on its potential. [WATCH TIME: 3 minutes]
Mechanistic Action and FDA Outlook for Omaveloxolone in Friedreich Ataxia: David R. Lynch, MD, PhD
September 27th 2021The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed whether omaveloxolone’s therapeutic benefit is enough for it to become the first approved therapy for Friedrich ataxia. [WATCH TIME: 2 minutes]
Developing Interventions to Address Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc
September 26th 2021The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]
COVID-19 Stressors and Mental Health in Parkinson Disease: Lisanne Dommershuijsen, MSc
September 25th 2021The PhD candidate in the epidemiology department at Erasmus University Medical Center in the Netherlands discussed the need for tailored treatment in light of the COVID-19 pandemic. [WATCH TIME: 4 minutes]